Steven Harr
Gründer bei SANA BIOTECHNOLOGY, INC.
Vermögen: 75 Mio $ am 30.04.2024
Aktive Positionen von Steven Harr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SANA BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 01.10.2018 | - |
Vorstandsvorsitzender | 01.09.2018 | - | |
Gründer | 13.07.2018 | - | |
Präsident | 01.09.2018 | - | |
JW Biotechnology (Shanghai) Co. Ltd. | Direktor/Vorstandsmitglied | - | - |
X-Body, Inc.
X-Body, Inc. BiotechnologyHealth Technology X-BODY, Inc. provides biotechnological research services. The company was founded on April 9, 2009 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | - | - |
Treasurer | - | - | |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.03.2020 | - |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Präsident | - | - |
Karriereverlauf von Steven Harr
Ehemalige bekannte Positionen von Steven Harr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LOXO ONCOLOGY INC | Direktor/Vorstandsmitglied | 07.11.2016 | 15.02.2019 |
Independent Dir/Board Member | 07.11.2016 | 15.02.2019 | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.02.2016 | 25.09.2018 |
Gründer | 01.02.2016 | 25.09.2018 | |
JUNO THERAPEUTICS INC | Finanzdirektor/CFO | 01.04.2014 | 01.03.2018 |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Analyst-Equity | 01.05.2010 | 01.04.2014 |
Vorstandsvorsitzender | 01.05.2010 | 01.04.2014 |
Ausbildung von Steven Harr
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 10 |
China | 3 |
Operativ
Director/Board Member | 6 |
Chief Executive Officer | 2 |
Founder | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SANA BIOTECHNOLOGY, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Finance |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
JW Biotechnology (Shanghai) Co. Ltd. | |
Loxo Oncology, Inc.
Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
X-Body, Inc.
X-Body, Inc. BiotechnologyHealth Technology X-BODY, Inc. provides biotechnological research services. The company was founded on April 9, 2009 and is headquartered in Waltham, MA. | Health Technology |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Steven Harr
- Erfahrung